{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"condition":["(borderline) resectable pancreatic adenocarcinoma","Colorectal liver metastases","Pancreas carcinoma resectable"],"disease":["Pancreas Carcinoma Resectable","(borderline) Resectable Pancreatic Adenocarcinoma","Colorectal Liver Metastases"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2442211"],"location":["Netherlands"],"study_start_month":["9"],"keyword":["MesoPher"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Minimally invasive, Indocyanine-Guided Metastasectomy in patients with Colorectal Liver Metastases","description":"Primary outcome(s): Percentage radical resections\nStudy Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other","dates":{"creation":"2018-09-15"},"accession":"2442211","cross_references":{"Netherlands National Trial Register":["NL7674"],"EU Clinical Trials Register":["2018-003222-92"]}}